TAG:
cap
Bio-Rad Buys Ciphergen’s Proteomics Technology
By Robert Michel | From the Volume XIII No. 12 – September 5, 2006 Issue
PROTEOMICS IS EXPECTED TO BE ONE of the most active areas in molecular diagnostics and Bio-Rad Laboratories, Inc. has just staked a major claim to a promising proteomic technology. In a transaction announced on August 18, 2006, Bio-Rad will acquire the proprietary proteomics instrum…
Siemens’ IVD Purchases Are a Major Investment
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In the space of just nine weeks, Siemens AG purchased Diagnostic Products Corp. (DPC) and Bayer Diagnostics. Siemens paid $1.86 billion and $5.31 billion, respectively, for the two invitro diagnostics (IVD) companies. Once it closes the acquisition of Bayer Diagnostics, Sieme…
IVD Executive Discusses Three Developing Trends
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In a refreshingly candid assessment of current technology published in IVD Technology magazine, one lab industry executive describes both the successes and the failings of analyzers, automation, and software. He offers three trends he expects will address the deficiencies of …
Pathologist-Entrepreneurs Offer New Lab Automation
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: Since October 2003, the core laboratory of Detroit Medical Center University Laboratories has operated with a home-grown total laboratory automation (TLA) system. The 100-foot automated line currently connects to 11 instruments and the hardware cost only $200,000 to build and…
August 14, 2006 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
Here’s some useful information for pathologists and practice administrators trying to gauge the interest that urologists, gastroenterologists, and dermatologists have in capturing the anatomic pathology revenues generated by their patient referrals (the TC/PC trend). Pathology Service Assoc…
Six Ex-IMPATH Officials Receive Their Sentences
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: Justice has been meted out to six individuals accused of criminal fraud in the Impath,Inc. case. During June, sentences were pronounced for former President and COO Richard P. Adelson and several other defendants. Adelson will serve 42 months in prison, pay a $1.2 million fin…
Defense Attorneys Discuss Details Of UroCor Jury Trial
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: This was the first criminal case involving anti-kickback violations brought against executives of a public laboratory company. Federal prosecutors charged the defendants with offering inducements to referring physicians in several ways. Defense counsel rebutted the prosecutio…
Pathology Clients Now Competing Against Pathologists
By R. Lewis Dark | From the Volume XIII No. 9 – July 3, 2006 Issue
THIS ENTIRE ISSUE IS DEVOTED TO A SINGLE TOPIC: the exploding interest by specialist physicians in establishing their own in-practice ancillary service in anatomic pathology (AP). Once again, THE DARK REPORT is first to provide the pathology profession with a concise and insightful assessment of a di…
Office-Based Docs Want Anatomic Path Revenues
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
CEO SUMMARY: Specialist physicians think they’ve found gold in anatomic pathology services. Indifferent regions of the United States, urologists and gastroenterologists are taking active steps to cut themselves a piece from the anatomic pathology revenue pie. Some physician groups are b…
Labs Taught Physicians How to Do TC/PC Deals
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
CEO SUMMARY: As many pathology groups discover that their best urology and gastroenterology clients are taking serious steps to do their own anatomic pathology, they ask a basic question: How did their best-referring…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized